Feasibility trial of mindfulness-based cognitive therapy (MBCT) follow-up programs for anxiety disorders
Phase 2
- Conditions
- Anxiety disorders
- Registration Number
- JPRN-UMIN000038626
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
Not provided
Exclusion Criteria
/Past history of substance related disorders /Alcohol dependence /Drug dependence /Anti social personality disorder /Severe suicidal ideation or self-harm behaviour /Difficult to follow up for 12 months after start of intervention /Dissent to the possibility of being allocated to the control group /Organic brain disorders /Other severe general medical conditions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) enrollment rate, 2) dropout rate, 3)retention rate, 4) mean and standardized deviation of the clinical parameters (STAI) at 5, 8, 12months
- Secondary Outcome Measures
Name Time Method mean and standardized deviation of the following clinical parameters at 5, 8, 12months: Panic disorder severity scale, Mobility inventory, LSAS-J, SF-36, SPANE, RSES, FFMQ, CD-RISC, SCS, QIDS, GAD7, PSS, HPQ, SWLS, FS, MAIA, EQ-5D, HAM-A, interoception, healthcare service usage, medication adherence, adherence to home work etc. Cost effectiveness will be assessed by Incremental Cost Effectiveness Ratio using quality adjusted life years as a clinical parameter.